Azacitidine and confusional state Patient Reports February 11, 2012

Azacitidine Side Effects Report #5607807-3
Azacitidine side effect was reported by a Physician from ITALY on Jan 18, 2008. Male patient, 85 years of age, weighting 145.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: angina pectoris, confusional state, constipation , intestinal obstruction, no therapeutic response, pleural effusion. Azacitidine dosage: (37.5 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ZOFRAN, GLYSENNID, UNIPRIL, MONOKET, METOPROLOL TARTRATE, ALLOPURINOL, PLASIL, PSYLOGEL. Patient was hospitalized. Patient recovered.

Azacitidine Side Effects Report #5500373-2
Azacitidine side effect was reported by a Physician from ITALY on Oct 11, 2007. Male patient, 84 years of age, weighting 145.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: angina pectoris, confusional state, pleural effusion, subileus. Azacitidine dosage: (37.5 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Azacitidine Side Effects Report #4950113-0
Azacitidine side effect was reported by a Physician from UNITED KINGDOM on Mar 01, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: clostridium colitis, confusional state, faecal incontinence, lethargy, lower respiratory tract infection, neutropenic sepsis, pancytopenia, virus stool test positive. Azacitidine dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LOPERAMIDE, VALACYCLOVIR, PROBAC, BIOMAGNESIUM, ACETAMINOPHEN, TELMISARTAN, RIFAMPICIN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Azacitidine Side Effects Report #5006543-4
Azacitidine side effect was reported by a Physician from AUSTRALIA on May 02, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, confusional state, dehydration, haemorrhoidal haemorrhage, lethargy, lower respiratory tract infection, neutropenic sepsis, pancytopenia. Azacitidine dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LOPERAMIDE, VALACYCLOVIR, PROBAC, BIOMAGNESIUM, ACETAMINOPHEN, TELMISARTAN, RIFAMPICIN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.


Azacitidine Side Effects Report #4854991-5
Azacitidine side effect was reported by a Physician from AUSTRALIA on Nov 30, 2005. Male patient, 63 years of age, weighting 157.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: agitation, anorexia, confusional state, febrile neutropenia, hyponatraemia, nausea , weight decreased. Azacitidine dosage: 37.5 MG/M2 (71 MG, DAILY X 7 DAYS) SUBCUTANEOUS. During the same period patient was treated with FOLIC ACID, HYDROXOCOBALAMIN, DEHYDROEPIANDROSTERONE, MOCLOBEMIDE, AMITRIPTYLINE, CALCIUM CARBONATE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Azacitidine Side Effects Report #4877274-6
Azacitidine side effect was reported by a Physician from AUSTRALIA on Dec 22, 2005. Male patient, 63 years of age, weighting 157.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: acute febrile neutrophilic dermatosis, agitation, blister, bronchopneumonia, candidiasis, confusional state, hyponatraemia, immunosuppression, lobar pneumonia. Azacitidine dosage: 37.5 MG/M2 (71 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FOLIC ACID, HYDROXOCOBALAMIN, DEHYDROEPIANDROSTERONE, MOCLOBEMIDE, AMITRIPTYLINE HYDROCHLORIDE, CALCIUM CARBONATE, MORPHINE SULPHATE, ALPRAZOLAM. Patient was hospitalized. Patient recovered.